Fresenius Medical Care AG & Co. KGaA
General ticker "FMCQF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $14.8B (TTM average)
Fresenius Medical Care AG & Co. KGaA does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 0.0%: low 44.25$, high 44.25$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-26, amount 1.62$ (Y3.66%)
- Total employees count: 47521 as of 2005
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [41.05$, 61.56$]
- 2025-12-31 to 2026-12-31 estimated range: [43.85$, 65.55$]
Financial Metrics affecting the FMCQF estimates:
- Negative: with PPE of 22.8 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 18.66 > 12.96
- Positive: -4.75 < Operating profit margin, % of 7.20
- Positive: 42.68 < Shareholder equity ratio, % of 43.43 <= 64.29
- Positive: -9.07 < Industry operating profit margin (median), % of -2.40
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.16
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 3.34
- Positive: Interest expense per share per price, % of 3.18 <= 3.28
- Negative: Investing cash flow per share per price, % of -0.66 <= -0.63
Short-term FMCQF quotes
Long-term FMCQF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €19,453.62MM | €19,335.91MM | €19,620.65MM |
| Operating Expenses | €18,084.18MM | €17,943.51MM | €17,783.34MM |
| Operating Income | €1,369.44MM | €1,392.39MM | €1,837.31MM |
| Non-Operating Income | €-336.42MM | €-335.47MM | €-325.88MM |
| Interest Expense | €424.64MM | €407.04MM | €384.86MM |
| R&D Expense | €231.97MM | €183.49MM | €157.94MM |
| Income(Loss) | €1,033.02MM | €1,056.93MM | €1,511.43MM |
| Taxes | €300.56MM | €316.06MM | €320.88MM |
| Profit(Loss)* | €499.00MM | €537.91MM | €977.63MM |
| Stockholders Equity | €13,620.26MM | €14,576.56MM | €13,304.85MM |
| Inventory | €2,179.18MM | €2,067.92MM | €2,140.20MM |
| Assets | €33,929.81MM | €33,566.58MM | €30,990.39MM |
| Operating Cash Flow | €2,628.80MM | €2,386.14MM | €2,679.99MM |
| Capital expenditure | €684.60MM | €699.36MM | €915.03MM |
| Investing Cash Flow | €-544.23MM | €-84.94MM | €-693.29MM |
| Financing Cash Flow | €-1,858.53MM | €-2,569.30MM | €-1,431.65MM |
| Earnings Per Share** | €1.70 | €1.83 | €3.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.